Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34416158

Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Sep
First author
Gaspar N

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Sep;22(9):1206-1207. doi: 10.1016/S1470-2045(21)00422-8.
    note
    Source null
    related pmid
    34416160
    relationship
    Comment in

Authors and identifiers

  1. name
    Gaspar N
    type
    Author
  2. name
    Venkatramani R
    type
    Author
  3. name
    Hecker-Nolting S
    type
    Author
  4. name
    Melcon SG
    type
    Author
  5. name
    Locatelli F
    type
    Author
  6. name
    Bautista F
    type
    Author
  7. name
    Longhi A
    type
    Author
  8. name
    Lervat C
    type
    Author
  9. name
    Entz-Werle N
    type
    Author
  10. name
    Casanova M
    type
    Author
  11. name
    Aerts I
    type
    Author
  12. name
    Strauss SJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Gaspar N
    type
    Author
  2. name
    Venkatramani R
    type
    Author
  3. name
    Hecker-Nolting S
    type
    Author
  4. name
    Melcon SG
    type
    Author
  5. name
    Locatelli F
    type
    Author
  6. name
    Bautista F
    type
    Author
  7. name
    Longhi A
    type
    Author
  8. name
    Lervat C
    type
    Author
  9. name
    Entz-Werle N
    type
    Author
  10. name
    Casanova M
    type
    Author
  11. name
    Aerts I
    type
    Author
  12. name
    Strauss SJ
    type
    Author
bibliography ids
  1. nci-bib-b0443815dc0a01b31a78ab84
book metadata
content sha256
8a37a14c96d9b2586bd4ecac075cc1672678b949a3e4a896361fc436d4ed9c4c
document type
citation
dois
  1. 10.1016/S1470-2045(21)00387-9
electronic publication date
display
2021 Aug 17
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34416158
immutable id
pubmed:34416158@8a37a14c96d9b2586bd4ecac075cc1672678b949a3e4a896361fc436d4ed9c4c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
9
name
The Lancet. Oncology
nlm unique id
100957246
pages
1312-1321
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Sep;22(9):1206-1207. doi: 10.1016/S1470-2045(21)00422-8.
    note
    Source null
    related pmid
    34416160
    relationship
    Comment in
outcomes validated
false
pmid
34416158
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
a17b5f30634cf77100172c0466bd8b637e1e9c4668215fe7c3758b241ffa8c0a
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Sep
precision
month
year
2021
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34416158/
title
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.

Preserved source evidence · Not medical advice